The year 2020 has been a nightmare for every person in the world. For the last almost a year, the whole world is in the shadow of fear. This fear is named "Coronavirus", also known as Kovid-19. However, the epidemic started in 2019. The virus, which originated from China, spread throughout the world in a few months. Due to this virus, people are imprisoned in homes. Many people have fallen victim to this, some are still suffering from it, so millions of people have lost their lives because of it. Many countries have been working hard to prepare the vaccine, the cure to survive this epidemic, for a long time.
After long hard work, they are also getting success and there is every hope that in some time the condition will become as normal as before this epidemic. At this time, people all over the world want that its vaccine can be made as soon as possible and can be removed from the fear of Kovid. The last year i.e. 2020 was full of bad news, but 2021 has started with good news. This is the news that people have been waiting for for a long time. This news is related to the Bovishield vaccine.
Covishield is a vaccine for covid-19. On January 1 this year, Oxford AstraZeneca's Corona vaccine "Covishield" was approved for use in an emergency. This is very good news. Know how effective Kovishield is and when it will be available. Union Health Minister Harsh Vardhan has also said that this vaccine will be available for free in the country. Let us know in detail about the Indian Vaccine Kovshield.
The Approved for Bovishield vaccine
Oxford-AstraZeneca vaccines are being developed in India with the Serum Institute of India based in Pune. He sought approval for the emergency use of this coronavirus vaccine. On the first day of the new year, members of the Subject Expert Committee (SEC) of India's Central Drug Standards Control Organization (CDSCO) approved the use of the Coronavirus vaccine Covishield of Oxford-AstraZeneca in an emergency. According to reports, the Subject Expert Committee (SEC) has approved the emergency use of this vaccine with certain conditions. The vaccine has been developed by scientists at the University of Oxford, UK, and produced by AstraZeneca. In the Subject Expert Committee meeting, Bharat Biotech gave its presentation for Kovashield by Kovaxin and Serum Institute. But the committee only approved the use of Kovishield. However, a little more waiting is still needed as the Controller General of India will also get the vaccine approved. For the final approval of this vaccine, the Drug Controller General of India (DCGI) V.G. Sent it to Somani. Even after getting approval from the Kovishild vaccine (Bovishield Vaccine) the dose may start to reach different parts of the country in a few days. SII CEO Adar Poonawalla has reported that 40–50 million doses of Bovishield vaccine have been stored and its rollout could begin in January.
Know about Bovishield vaccine,
Covishield is composed of a weak and modified version of adenovirus (a common cold virus). Which causes infection in chimpanzees and contains genetic items of the SARS-CoV-2 virus spike protein. According to SII CEO Adar Poonawala, he has worked hard for the last 7 -8 months in making this vaccine. For so long, they have been making this vaccine and now they have ready doses in lakhs. Adar Poonawalla says that the biggest challenge in creating this vaccine, which was in front of him, was "less time". With this, he did not even know if this vaccine would work. Typically, each vaccine is waited for before its phase-3 is finished, and the product is made after that. However, he had to invest a lot in advance for this vaccine. Right now they have about 50 million (50 million) doses of this vaccine ready, enough for 25 million (25 million) people. They are continuously producing this vaccine and in the coming time, this product will be increased. This company also believes that in the coming time, that is, in two or three months, they will be able to prepare a dose of about ten crore cover shield vaccines. Not only this, in the first phase of vaccination in India, about 300 million people will be allowed to use this vaccine. Complete preparation for this has also been done.
Storestored
This vaccine is at a very low temperature. The AstraZeneca-Oxford Kovid-19 vaccine can be stored, stored, and transported from one place to another in normal refrigerated conditions (2 ° C to 8 ° C) for at least six months. However, cold storage is less in our country, so it can definitely be the cause of a problem. It is also believed that a bottle of Bovishield vaccine has ten doses in-store, and once opened, it is mandatory to use it within four or five hours. The currently prepared vaccine is placed in cold storage with the correct packing. Where full attention has also been given to their safety.
Effect
Every person must take two doses for this Bovishield vaccine. According to experts, this Kovid-19 vaccine has shown an efficacy of 90 percent and 62 percent. Among people who have taken both full doses within a month, its effect is seen to be 62 percent. At the same time, the effect of this vaccine has been seen to be 90 percent in those who took the first dose and completed the second. According to Adar Poonawala, the difference between the two doses is necessary to increase its effect.
Price
Bovishield vaccine is not priced higher than other medicines. If you take this vaccine from a government store, then one dose of it will be only 400 rupees and if you take it from its private store, you will get 700-800. However, the Union Health Minister has recently made it clear that the corona vaccine will be given free of cost throughout the country.
The side effect
coronavirus has killed many people in India for the last one year. There are still many cases of this being reported daily. In such a situation, everyone can breathe a sigh of relief from the approval of this vaccine. Each vaccine may have some side effects. However, the Bovishield vaccine is considered completely safe. During its trial, people complained of mild headaches and fever, but this is very common. It is also believed that these common side-effects are cured in a day or two.
Who will get this vaccine First,
Union Health Minister Harsh Vardhan had already made it clear that the vaccine of Coronavirus will be given to the health workers first. This vaccine will then be given to older people or those who are suffering from other diseases. This vaccine is being produced in India, so first it will be used only in India. However, later it can be exported to other countries as well. This vaccine is effective not only for young but also for older people. Therefore, this vaccine is considered to be excellent.
From January 2, a dry run of the Bovishield vaccine will be done in every state of India. Dry run means following the procedure that will be done at the time of vaccination without using the vaccine. This process checks whether the whole process will work properly or not. Vaccination will start in the country only after the approval of the Drug Controller General of India after the dry run. Along with Kovishield, in our country are coronavirus two other vaccines the also in the final phase. If they also get approval in the coming days, then people of a more populous country like India can get more relief. Hopefully, after the vaccination with the Bovishield vaccine in the coming days, we can all have a normal life. Till then stay in the house as much as possible and follow the rules stated by the government. Also, be prepared for vaccination.
 Approved for Emergency Use){kind=link}
0 Comments